Tuesday, May 21, 2024

The 340B Drug Pricing Program: Trends, Controversies, and Outlook (NEW Live Video Webinar)

Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels, invites you to join him for DCI’s new live video webinar:

This event will be broadcast live on
Friday, June 21, 2024, from 12:00 p.m. to 1:30 p.m. ET

This page describes the event and explains how to purchase a registration. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia.

This event is part of The Drug Channels 2024 Video Webinar Series.


The federal 340B Drug Pricing Program continues to grow much more quickly than the overall pharmaceutical market. For 2023, total purchases under the 340B program exceeded $124 billion. DCI estimates that 340B discounts equated to more than 17% of total value of gross-to-net reductions for brand-name pharmaceuticals. The 340B program also remains a significant and controversial source of profits for the pharmacy and pharmacy benefit management (PBM) industries.

In this all-new webinar, Dr. Fein will provide a fact-based look at the 340B program, summarize the multiple controversies surrounding the program’s operations, and deliver a clear-eyed outlook for the program’s future. Key topics will include:
  • Current operations of the 340B program
  • 340B growth trends by dispensing/administration channel and covered entity type
  • Following the 340B dollar
  • Contract pharmacy controversies
  • Impact of CMS’s latest 340B guidance for the Inflation Reduction Act
  • PBM and pharmacy profits from the 340B program
  • Vertical integration and third-party administrators
  • How state Medicaid program reforms are affecting the 340B program
  • Manufacturers’ 340B strategies
  • State and federal legislative actions and outlook
  • And much more!
PLUS: During the webinar, Dr. Fein will give participants an opportunity to unmute themselves and ask live questions. The webinar will last at least 90 minutes to accommodate audience questions.

As always, Dr. Fein will clearly distinguish his opinions and interpretations from the objective facts and data. He will also draw from exclusive information found in DCI's 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers.

Read on for full details on pricing and registration.


You can register for this unique educational opportunity for only $400 per viewing device. Within 24 hours of your purchase, you will receive an email from Zoom with a unique link to access the event and add it to your calendar.

We are offering substantial discounts for multiple registrations from the same organization. We know that many of you are now working remotely, so rates for multiple registrations are as low as $280 per device—a 30% savings. An unlimited number of people may watch at one physical location if they can watch from a single device. Please note that a device at a single physical location may not stream, share, or project our webinar to other sites, devices, or locations. Each device at a physical location requires its own registration.

Click here to order. All discounts will be automatically computed based on the number of registrations you enter in your cart. (You can reset the cart by entering 0 in the quantity field.)

Please contact Paula Fein (paula@drugchannels.net) if you have any questions. If you purchase access for multiple devices, we will contact you for a list of your participants and their email addresses. Or, download this spreadsheet and email your registrants’ information to dcisupport@hmpglobal.com.

Payment can be made with all major credit cards (Visa, MasterCard, American Express, and Discover) or via PayPal. Click here to email us if you would like to pay by corporate purchase order or check.

  • Watch and listen via any device with a web browser (computer, iPad, iPhone/Android, etc.) There is no access via telephone.
  • We will use Zoom technology for this webinar. Every registrant will receive an email from Zoom with a link to watch the event. This link is unique to the registrant and can only be accessed once. We recommend that every registrant download the Zoom client software/app.
  • Every registrant will receive an email from Zoom with links to download Dr. Fein’s slides.
  • The day after the event, every registrant—whether they attended the live event or not—will receive an email from Zoom with links to sign up for a replay of the event and download Dr. Fein’s slides.
  • This event is part of The Drug Channels 2024 Video Webinar Series. If you already purchased access to the 2024 Drug Channels Video Webinar Series, then you should have received an email from Zoom with a link to access the June 21 event.
  • Organizations that purchased corporate access for The Drug Channels 2024 Video Webinar Series will receive a custom, branded signup link so employees can easily register. We will automatically refund payments from anyone at a company with corporate access who purchases a single registration using their corporate email account.
  • Each registration for a DCI webinar is valid for a single device at a single physical location. Each device at a physical location requires its own registration. Attendees are not permitted to stream, share, or project a DCI webinar to other sites or locations. Purchasers who violate this limitation by streaming, sharing, or projecting a DCI webinar to other sites, devices, or locations will be liable for the full cost of all locations that viewed the webinar. DCI reserves the right to prohibit purchasers who violate our terms from attending future DCI webinars.
  • Unfortunately, we are unable to offer refunds.

No comments:

Post a Comment